Research.Patient.info

Respiratory Syncytial Virus (RSV) prophylaxis (vaccination) research hub

1 indexed studies · 0 currently recruiting

authorisedTherapeutic use (Phase IV)
A Single-Blind, Randomized, Placebo-Controlled Trial Evaluating the Impact of Clesrovimab on Nasopharyngeal Shedding of RSV and Other Viral and Bacterial Respiratory Pathogens in Infants: The RSV-SHIELD Trial
This study looks at a medicine called clesrovimab (Enflonsia) in babies. Researchers want to see how well it protects infants from respiratory syncytial virus (RSV). They also want to find out if it reduces how long the virus stays in the nose and if it affects other common germs.
Greece